Vinorelbine

In the US, Vinorelbine (vinorelbine systemic) is a member of the drug class mitotic inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01CA04

CAS registry number (Chemical Abstracts Service)

0071486-22-1

Chemical Formula

C45-H54-N4-O8

Molecular Weight

778

Therapeutic Categories

Cytostatic agent

Microtubule inhibitor

Vinca alkaloid

Chemical Name

3',4'-Didehydro-4'-deoxy-8'-norvincaleukoblastine (WHO)

Foreign Names

Generic Names

  • Vinorelbine (OS: DCF, BAN)
  • 5'-Noranhydrovinblastine (IS)
  • KW 2307 base (IS)
  • UNII-Q6C979R91Y (IS)
  • Vinorelbine (PH: USP 28)
  • Vinorelbine Ditartrate (OS: JAN)
  • Vinorelbine Tartrate (OS: BANM, USAN)
  • Didehydrodeoxynorvincaleukoblastine (IS)
  • KW-2307 (IS)
  • UNII-253GQW851Q (IS)
  • Vinorelbin bitartrate (IS)
  • Vinorelbine hydrogentartrate (IS)
  • Vinorelbine tartrate (PH: Ph. Eur. 7)
  • Vinorelbine Tartrate (PH: BP 2011, USP 34)
  • Vinorelbini tartras (PH: Ph. Eur. 7)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web5)